+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Sterile Injectable Drugs - Global Market Trajectory & Analytics

  • ID: 5310773
  • Report
  • April 2021
  • Region: Global
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • AstraZeneca PLC
  • Gilead Sciences, Inc.
  • GlaxoSmithKline PLC
  • Pfizer, Inc.
  • Science, Inc.
Global Sterile Injectable Drugs Market to Reach $929.3 Billion by 2027

Amid the COVID-19 crisis, the global market for Sterile Injectable Drugs estimated at US$486.6 Billion in the year 2020, is projected to reach a revised size of US$929.3 Billion by 2027, growing at a CAGR of 9.7% over the period 2020-2027. Small Molecule, one of the segments analyzed in the report, is projected to record 9.4% CAGR and reach US$390.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Large Molecule segment is readjusted to a revised 9.9% CAGR for the next 7-year period.





The U.S. Market is Estimated at $144.2 Billion, While China is Forecast to Grow at 9.1% CAGR

The Sterile Injectable Drugs market in the U.S. is estimated at US$144.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$161 Billion by the year 2027 trailing a CAGR of 9.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.2% and 7.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.7% CAGR.

Select Competitors (Total 42 Featured):
  • AstraZeneca PLC
  • Gilead Sciences, Inc.
  • GlaxoSmithKline PLC
  • Pfizer, Inc.
  • Science, Inc.
Frequently Asked Questions about the Global Market for Sterile Injectable Drugs

What is the estimated value of the Global Market for Sterile Injectable Drugs?

The Global Market for Sterile Injectable Drugs was estimated to be valued at $486.6 Billion in 2020.

What is the growth rate of the Global Market for Sterile Injectable Drugs?

The growth rate of the Global Market for Sterile Injectable Drugs is 9.7%, with an estimated value of $929.3 Billion by 2027.

What is the forecasted size of the Global Market for Sterile Injectable Drugs?

The Global Market for Sterile Injectable Drugs is estimated to be worth $929.3 Billion by 2027.

Who are the key companies in the Global Market for Sterile Injectable Drugs?

Key companies in the Global Market for Sterile Injectable Drugs include AstraZeneca PLC, Gilead Sciences, Inc., GlaxoSmithKline PLC and Science, Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AstraZeneca PLC
  • Gilead Sciences, Inc.
  • GlaxoSmithKline PLC
  • Pfizer, Inc.
  • Science, Inc.

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
  • UNITED STATES
  • CANADA
  • JAPAN
  • CHINA
  • EUROPE
  • FRANCE
  • GERMANY
  • ITALY
  • UNITED KINGDOM
  • REST OF EUROPE
  • ASIA-PACIFIC
  • REST OF WORLD

IV. COMPETITION
  • Total Companies Profiled: 42
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • AstraZeneca PLC
  • Gilead Sciences, Inc.
  • GlaxoSmithKline PLC
  • Pfizer, Inc.
  • Science, Inc.
Note: Product cover images may vary from those shown